Induction chemotherapy in the management of squamous cell carcinoma of the head and neck Review

Roman, E, Raez, LE, Santos, ES. (2006). Induction chemotherapy in the management of squamous cell carcinoma of the head and neck . Expert Review of Anticancer Therapy, 6(9), 1205-1215. 10.1586/14737140.6.9.1205

cited authors

  • Roman, E; Raez, LE; Santos, ES

abstract

  • Platinum-based chemotherapy administered concurrently with radiation has been adopted as the standard treatment for locally advanced head and neck squamous cell carcinoma. Historically, randomized trials using induction chemotherapy prior to radiation therapy alone have failed to demonstrate a clear survival advantage, and concurrent chemoradiation has delivered better results than previously obtained with radiation therapy alone, establishing the benefit of adding chemotherapy. This method of treatment, together with new modalities of therapy and novel agents, has reintroduced the question of induction chemotherapy before definitive chemoradiation. Systemic chemotherapy offers a better possibility of reducing systemic metastasis and improving cosmetic appearance. This article reviews developing trends using induction chemotherapy followed by chemoradiation in patients with head and neck squamous cell carcinoma. © 2006 Future Drugs Ltd.

authors

publication date

  • September 1, 2006

published in

Digital Object Identifier (DOI)

start page

  • 1205

end page

  • 1215

volume

  • 6

issue

  • 9